Keep up with the doctors, patients, treatments—and results—from all our locations.
The pharmaceutical world was shaken up in May 2014 as Allergan, the manufacturer of the best-selling synthetic neurotoxin Botox®, drew a merger bid of nearly $50 billion from rival pharmaceutical giant Valeant. At the time the bid was tendered, Allergan was also celebrating the 25th anniversary of Botox®, which has been credited with being one of the factors that inspired the development of surgery as a viable option for qualified patients who suffer from chronic migraines.
The world of professional and competitive cycling has undergone a lot of scrutiny due to the scandalous reports of performance-enhancement drug use among stars of the sport. One of the most infamous cases in this regard involves American racer Lance Armstrong, but current news headlines are being made by former British professional racer Michael Barry, who rode for the Sky Team and confessed to have furtively used Tramadol while racing in 2010.
Viral hoaxes and pranks that play out on online social networks are among the most interesting sociological developments of 21st century Internet life. On the eve of April Fools' Day 2014, an alleged news report of teenagers in the United States smoking coffee beans rolled up into “caffeine sticks” dominated Facebook, Twitter and other social media platforms, but the reports could not truly be substantiated at the time.
The Cefaly device was approved by the U.S. Food and Drug Administation on Tuesday. This is the first device that the FDA has approved that is said to prevent migraine headaches.
If you suffer from migraines, then you know how difficult it can be to continue your regular activities when you are having an attack. Everyone’s migraines are different, and you will have to experiment with different remedies and strategies to help you discover the best ways to get rid of a severe headache. Here are a few things that you can try to minimize your migraine pain and suffering the next time you get a migraine headache.
